References


  1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV & AIDS Statistics – 2019 Fact Sheet; 2019. Available at: https://www.unaids.org/en/resources/fact-sheet (last accessed 20 April 2020).
  2. Kirby Institute. Australian National HIV Surveillance Data 2019. 2020. Available at: https://data.kirby.unsw.edu.au/hiv (last accessed 20 April 2020).
  3. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney; 2018. Available at: https://kirby.unsw.edu.au/sites/default/files/kirby/report/KI_Annual-Surveillance-Report-2018.pdf  (last accessed 20 April 2020).
  4. World Health Organization (WHO). Guidelines on hepatitis B and C testing. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO
  5. Australian Government. Attorney-General’s Department. Australia’s anti-discrimination law [internet]. Available at: https://www.ag.gov.au/RightsAndProtections/HumanRights/Pages/Australias-Anti-Discrimination-Law.aspx  (last accessed 19 July 2019).
  6. Australasian Society for HIV Viral Hepatitis and Sexual Health Medicine. Guide to Australian HIV Laws and Policies for Healthcare Professionals. Available at: https://hivlegal.ashm.org.au/safe-behaviours-and-disclosure/ (last accessed 12 February 2020).
  7. Australian Government. Department of Health. Pathology under Medicare [internet]. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pathology-aboutus-index.htm  (last accessed 19 July 2019).
  8. Keen P, Conway DP, Cunningham P, et al. Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays. J Clin Virol 2017;86:46-51.
  9. Conway DP, Holt M, McNulty A, et al. Sydney Rapid HIV Test Study. Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One 2014;9:e94062.
  10. Krause J, Subklew-Sehume F, Kenyon C, et al. Acceptability of HIV self-testing: a systematic literature review. BMC Public Health 2013;13:735-43.
  11. Jamil MS, Prestage G, Fairley CK, et al. Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial. Lancet HIV 2017;4:e241-e250.
  12. NSW Government. Ministry of Health. NSW HIV Strategy 2016-2020 Data Report. Quarter 4 and Annual 2017. Sydney: NSW Ministry of Health; 2018.
  13. Fisher M, Wayal S, Smith H, et al. Home sampling for sexually transmitted infections and HIV in men who have sex with men: a prospective observational study. PLoS ONE 2015;10:e0120810.
  14. van Loo IHM, Dukers-Muijrers NHTM, Heuts R, et al. Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling. PLoS ONE 2017;12:e0186722.
  15. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney; 2018. Available at: https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance (last accessed 19 July 2019).
  16. Walensky RP, Weinstein MC, Kimmel AD, Seage III GR, Losina E, Sax PE, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. The American journal of Medicine 2005;118(3):292-300.
  17. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Post-exposure prophylaxis after non-occupational and occupational exposure to HIV. Australian National Guidelines (second edition). August 2016. Available at: https://www.ashm.org.au/HIV/PEP/ (last accessed 19 July 2019).
  18. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018. Available at: http://viruseradication.com/journal-details/Australasian_Society_for_HIV,_Viral_Hepatitis_and_Sexual_Health_Medicine_HIV_pre-exposure_prophylaxis:_clinical_guidelines._Update_April_2018/ (last accessed 19 July 2019).
  19. Birrell F, Staunton S, Debattista J, et al. Pilot of non-invasive (oral fluid) testing for HIV within a community setting. Sex Health 2010;7:11-16.
  20. Pedrana AE, Hellard ME, Wilson K, et al. High rates of undiagnosed HIV infections in a community sample of gay men in Melbourne, Australia. J Acquir Immune Defic Syndr 2012;59:94-9.
  21. Holt M, Lea T, Asselin J, et al. The prevalence and correlates of undiagnosed HIV among Australian gay and bisexual men: results of a national, community-based, bio-behavioural survey. J Int AIDS Soc 2015;18:20526.
  22. World Health Organization. Biobehavioral survey guidelines for populations at risk for HIV. Geneva: World Health Organization; 2017.
  23. Stoové M, Asselin J, Pedrana A, et al. Declining prevalence of undiagnosed HIV in Melbourne: results from community-based bio-behavioural studies of gay and bisexual men. Aust N Z J Public Health 2017;42:57-61.
  24. Keen P, Lee E, Grulich A, et al. NSW HIV Prevention Partnership Project. Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, NSW coincident with increased testing and PrEP use: results from repeated, bio-behavioural studies. JIADS. 2020. doi: 10.1097/QAI.0000000000002451
  25. Joint United Nations Programme on HIV/AIDS (UNAIDS). WHO, UNAIDS statement on HIV testing services: new opportunities and ongoing challenges. 2017. Available at: https://www.unaids.org/sites/default/files/media_asset/2017_WHO-UNAIDS_statement_HIV-testing-services_en.pdf (last accessed 6 January 2020).
  26. Dr Elizabeth Woodcock & Associates. Clinical psychologists, Sydney [website]. HIV, AIDS, hep C and psychological issues [internet] 2014-15. Available at: http://www.woodcockpsychology.com.au/hiv-aids-hep-c-and-psychological-issues/  (last accessed 19 July 2019).
  27. Sherr L, Nagra N, Kulubya G, et al. HIV infection associated post-traumatic stress disorder and post-traumatic growth – a systematic review. Psychol Health Med 2011;16:612–29.
  28. Theuninck AC, Lake N, Gibson S. HIV-related posttraumatic stress disorder: investigating the traumatic events. AIDS Patient Care STDS 2010;24:485–91.
  29. McNally S, Dutertre S. Access to HIV prevention information among selected culturally and linguistically diverse (CALD) communities in Victoria. La Trobe University, Australian Research Centre in Sex, Health and Society. Melbourne: Latrobe University; 2006.
  30. Saha S, Sanders DS, Korthuis PT, et al. The role of cultural distance between patient and provider in explaining racial/ethnic disparities in HIV care. Patient Educ Couns 2011;85:e278–84.
  31. Newman CE, Bonar M, Greville HS, et al. Barriers and incentives to HIV treatment uptake among Aboriginal people in Western Australia. AIDS 2007;21:S13–S17.
  32. Ward JS, Hawke K, Guy RJ. Priorities for preventing a concentrated HIV epidemic among Aboriginal and Torres Strait Islander Australians. Med J Aust 2018;209:56.
  33. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). The Australian standards for psychological support for adults with HIV. 2017. Available at:  https://www.ashm.org.au/products/product/9781920773717  (last accessed 19 July 2019).
  34. Communicable Diseases Network Australia (CDNA). Australian national guidelines for the management of healthcare workers living with blood borne viruses and healthcare workers who perform exposure prone procedures at risk of exposure to blood borne viruses. Canberra: CDNA; 2018.
  35. Australian Government. Department of Health. Therapeutic Drugs Administration. Clinical performance requirements and risk mitigation strategies for HIV tests. Version 1.0, March 2015. Available at: https://www.tga.gov.au/publication/clinical-performance-requirements-and-risk-mitigation-strategies-hiv-tests  (last accessed 19 July 2019).
  36. Australian Government. Department of Health. Pregnancy Care Guidelines. 33 Human immunodeficiency virus [internet]. Updated 17 May 2019. Available at : https://www.health.gov.au/resources/pregnancy-care-guidelines/part-f-routine-maternal-health-tests/human-immunodeficiency-virus (last accessed 9 January 2020).
  37. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Routine antenatal assessment in the absence of pregnancy complications. Updated November 2019. Available at: https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Routine-antenatal-assessment-in-the-absence-of-pregnancy-complications-(C-Obs-3b)_2.pdf?ext=.pdf  (last accessed 5 January 2020).
  38. Sydney Children’s Hospital. Paediatric HIV Service. Antenatal screening for HIV: information for health professionals. December 2011. Available at: http://testingportal.ashm.org.au/library/item/antenatal-screening-for-hiv-information-for-health-professionals  (last accessed 19 July 2019).
  39. NSW Government. Ministry of Health. The NSW Framework and Standard Operating Procedure for HIV Point of Care Testing. GL2019_010. Available at: https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2019_010.pdf (last accessed 8 January 2020).